The Greater Cannabis Company, Inc. (GCAN) 은(는) 상장 기업입니다 헬스케어 섹터의 Drug Manufacturers - Specialty & Generic 산업에서 운영. 본사 소재지는 Baltimore, MD, 미국. 현재 CEO는 Aitan Zacharin.
GCAN 을(를) 보유 IPO 날짜 2018-09-18, 1 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $188.15K.
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company was founded in 2014 and is based in Baltimore, Maryland.
